These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 24352761

  • 21. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X, Shen Y, Zheng S, Liu J, Jiang X.
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z, Zhang Y, Zhang X, Zhang M, Liu H, Zhang S, Qi B, Sun X.
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [Abstract] [Full Text] [Related]

  • 28. miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.
    Chen J, Zhou J, Chen X, Yang B, Wang D, Yang P, He X, Li H.
    Tumour Biol; 2015 Sep; 36(10):8221-9. PubMed ID: 26002578
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma.
    Cai H, Lin L, Cai H, Tang M, Wang Z.
    Med Oncol; 2013 Jun; 30(2):499. PubMed ID: 23430441
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
    Chen Z, Zhao G, Zhang Y, Ma Y, Ding Y, Xu N.
    J BUON; 2018 Jun; 23(6):1816-1824. PubMed ID: 30610808
    [Abstract] [Full Text] [Related]

  • 34. MiRNA-221 from tissue may predict the prognosis of patients with osteosarcoma.
    Gong N, Gong M.
    Medicine (Baltimore); 2018 Jul; 97(29):e11100. PubMed ID: 30024497
    [Abstract] [Full Text] [Related]

  • 35. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W, Zhao ZY, Shi L, Yuan WD.
    Diagn Pathol; 2015 Jul 21; 10():116. PubMed ID: 26194657
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ezrin expression predicts survival in stage IIB osteosarcomas.
    Kim MS, Song WS, Cho WH, Lee SY, Jeon DG.
    Clin Orthop Relat Res; 2007 Jun 21; 459():229-36. PubMed ID: 17353802
    [Abstract] [Full Text] [Related]

  • 38. Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma.
    Li Z, Liao Q, Wu Y, Liao M, Hao Y, Zhang S, Song S, Li B, Zhang YD.
    Pathol Oncol Res; 2012 Jul 21; 18(3):657-61. PubMed ID: 22215309
    [Abstract] [Full Text] [Related]

  • 39. Decreased miR-134 expression and its tumor-suppressive function in human osteosarcoma.
    Bao Y, Peng L, Ma J, Liu K, Li W.
    Genet Mol Res; 2015 Dec 14; 14(4):16771-81. PubMed ID: 26681023
    [Abstract] [Full Text] [Related]

  • 40. MicroRNA-532-5p is a prognostic marker and inhibits the aggressive phenotypes of osteosarcoma through targeting CXCL2.
    Ma Y, Zhao HX, Shi YJ, Cheng MG.
    Kaohsiung J Med Sci; 2020 Nov 14; 36(11):885-894. PubMed ID: 32643867
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.